Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The esophageal and gastric mucosa are the innermost cellular linings of the esophagus and stomach, respectively. The esophageal mucosa is lined by stratified squamous epithelium and serves as a protective barrier against mechanical injury and acid exposure, while the gastric mucosa is lined by columnar epithelium that secretes mucus, acid, and various digestive enzymes[3][5][7]. Both play critical roles in protecting underlying tissues, facilitating digestion, and mediating immune defense. Diseases involving these tissues include reflux esophagitis, gastritis, ulcers, and cancer. Additional clarification: This entry is not a canonical drug target but a general histological tissue type comprising multiple cell types and molecular targets. Therapeutic and diagnostic interventions generally focus on molecular components (e.g., H^+/K^+-ATPase in parietal cells), not "mucosa" as an entity[3][5][7].
Acid suppression, Mucosal protection, Barrier enhancement, Anti-inflammatory actions
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Esophageal and gastric mucosa.